3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
3
Phase NA
2
Phase 2
2
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Plasma cell
2
Other hematologic neoplasm
2
Myeloid
1
Classical hematology
1
Conditions
Thrombocytopenia
1
Myelodysplastic Syndromes
1
Leukemia
1
Hematologic Neoplasms
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Cyclophosphamide
34
Cytarabine
33
Exercise
26
Blood Specimen Collection
24
venetoclax
23
fludarabine phosphate
22
Busulfan
22
fludarabine
18
Methotrexate
18
Methods
18
Cyclosporine
18
Peripheral Blood Stem Cell Transplantation
17
Filgrastim
17
Antilymphocyte Serum
17
Standard of Care
16
Whole-Body Irradiation
15
Granulocyte Colony-Stimulating Factor
15
Educational Status
15
Early Intervention, Educational
15
Palliative Care
14
Melphalan
14
Daunorubicin
14
Mycophenolic Acid
13
Azacitidine
13
Practice Guidelines as Topic
12
Etoposide
12
Dexamethasone
12
Radiotherapy
11
Interviews as Topic
10
Vincristine
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase NA
×
Platelet Transfusion
×
Other hematologic neoplasm
×
Clear all
NCT04454723
2024-03-05
PalliaQOL
University of Oklahoma
Phase NA
Completed
20 enrolled
NCT01615146
2015-09-02
OPTIMAL
Ottawa Hospital Research Institute
Phase NA
Terminated
9 enrolled